Danaher Corp. closed 33.68% short of its 52-week high of $281.70, which the company achieved on August 1st.

We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to ...

$100,000 of DANAHER CORPORATION lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Education campaign with policymakers ...

The in-vitro diagnostics market is projected to experience positive revenue growth due to factors such as the rising incidence of infectious diseases like COVID-19, an increasing prevalence of various ...

A daily rundown of the economic reports and corporate earnings that will be grabbing the market’s attention in the week ahead ...

Shares of Sartorius (OTCPK:SARTF) spiked in European trading on Wednesday after the German life sciences company recorded a ...

The dental biomaterials market is projected to grow at a CAGR of ~8% over the forecast period. Major factors driving the growth include the increasing prevalence of dental disorders, growing demand ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The global histology and cytology market size is expected to reach USD 36.81 billion by 2027. Global Histology and Cytology Market Report added by Report Ocean, is an in-depth analysis of market ...

According to Vantage Market Research, the Global Flow Cytometry Market is estimated to be valued at USD 14 Billion by 2035 at ...